285 related articles for article (PubMed ID: 22181350)
1. First-in-class small molecule inhibitors of the single-strand DNA cytosine deaminase APOBEC3G.
Li M; Shandilya SM; Carpenter MA; Rathore A; Brown WL; Perkins AL; Harki DA; Solberg J; Hook DJ; Pandey KK; Parniak MA; Johnson JR; Krogan NJ; Somasundaran M; Ali A; Schiffer CA; Harris RS
ACS Chem Biol; 2012 Mar; 7(3):506-17. PubMed ID: 22181350
[TBL] [Abstract][Full Text] [Related]
2. Small-molecule APOBEC3G DNA cytosine deaminase inhibitors based on a 4-amino-1,2,4-triazole-3-thiol scaffold.
Olson ME; Li M; Harris RS; Harki DA
ChemMedChem; 2013 Jan; 8(1):112-7. PubMed ID: 23180603
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the anti-viral APOBEC3G catalytic domain and functional implications.
Holden LG; Prochnow C; Chang YP; Bransteitter R; Chelico L; Sen U; Stevens RC; Goodman MF; Chen XS
Nature; 2008 Nov; 456(7218):121-4. PubMed ID: 18849968
[TBL] [Abstract][Full Text] [Related]
4. The local dinucleotide preference of APOBEC3G can be altered from 5'-CC to 5'-TC by a single amino acid substitution.
Rathore A; Carpenter MA; Demir Ö; Ikeda T; Li M; Shaban NM; Law EK; Anokhin D; Brown WL; Amaro RE; Harris RS
J Mol Biol; 2013 Nov; 425(22):4442-54. PubMed ID: 23938202
[TBL] [Abstract][Full Text] [Related]
5. Small-Angle X-ray Scattering (SAXS) Measurements of APOBEC3G Provide Structural Basis for Binding of Single-Stranded DNA and Processivity.
Barzak FM; Ryan TM; Mohammadzadeh N; Harjes S; Kvach MV; Kurup HM; Krause KL; Chelico L; Filichev VV; Harjes E; Jameson GB
Viruses; 2022 Sep; 14(9):. PubMed ID: 36146779
[TBL] [Abstract][Full Text] [Related]
6. Structure of the DNA deaminase domain of the HIV-1 restriction factor APOBEC3G.
Chen KM; Harjes E; Gross PJ; Fahmy A; Lu Y; Shindo K; Harris RS; Matsuo H
Nature; 2008 Mar; 452(7183):116-9. PubMed ID: 18288108
[TBL] [Abstract][Full Text] [Related]
7. The DNA deaminase activity of human APOBEC3G is required for Ty1, MusD, and human immunodeficiency virus type 1 restriction.
Schumacher AJ; Haché G; Macduff DA; Brown WL; Harris RS
J Virol; 2008 Mar; 82(6):2652-60. PubMed ID: 18184715
[TBL] [Abstract][Full Text] [Related]
8. Inhibiting APOBEC3 Activity with Single-Stranded DNA Containing 2'-Deoxyzebularine Analogues.
Kvach MV; Barzak FM; Harjes S; Schares HAM; Jameson GB; Ayoub AM; Moorthy R; Aihara H; Harris RS; Filichev VV; Harki DA; Harjes E
Biochemistry; 2019 Feb; 58(5):391-400. PubMed ID: 30418757
[TBL] [Abstract][Full Text] [Related]
9. Biochemical analysis of hypermutation by the deoxycytidine deaminase APOBEC3A.
Love RP; Xu H; Chelico L
J Biol Chem; 2012 Aug; 287(36):30812-22. PubMed ID: 22822074
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel HIV-1 inhibitor targeting Vif-dependent degradation of human APOBEC3G protein.
Pery E; Sheehy A; Nebane NM; Brazier AJ; Misra V; Rajendran KS; Buhrlage SJ; Mankowski MK; Rasmussen L; White EL; Ptak RG; Gabuzda D
J Biol Chem; 2015 Apr; 290(16):10504-17. PubMed ID: 25724652
[TBL] [Abstract][Full Text] [Related]
11. Restriction of HIV-1 by APOBEC3G is cytidine deaminase-dependent.
Browne EP; Allers C; Landau NR
Virology; 2009 May; 387(2):313-21. PubMed ID: 19304304
[TBL] [Abstract][Full Text] [Related]
12. APOBEC3G enhances lymphoma cell radioresistance by promoting cytidine deaminase-dependent DNA repair.
Nowarski R; Wilner OI; Cheshin O; Shahar OD; Kenig E; Baraz L; Britan-Rosich E; Nagler A; Harris RS; Goldberg M; Willner I; Kotler M
Blood; 2012 Jul; 120(2):366-75. PubMed ID: 22645179
[TBL] [Abstract][Full Text] [Related]
13. HIV-1 Vif can directly inhibit apolipoprotein B mRNA-editing enzyme catalytic polypeptide-like 3G-mediated cytidine deamination by using a single amino acid interaction and without protein degradation.
Santa-Marta M; da Silva FA; Fonseca AM; Goncalves J
J Biol Chem; 2005 Mar; 280(10):8765-75. PubMed ID: 15611076
[TBL] [Abstract][Full Text] [Related]
14. Endogenous origins of HIV-1 G-to-A hypermutation and restriction in the nonpermissive T cell line CEM2n.
Refsland EW; Hultquist JF; Harris RS
PLoS Pathog; 2012; 8(7):e1002800. PubMed ID: 22807680
[TBL] [Abstract][Full Text] [Related]
15. Antiviral function of APOBEC3G can be dissociated from cytidine deaminase activity.
Newman EN; Holmes RK; Craig HM; Klein KC; Lingappa JR; Malim MH; Sheehy AM
Curr Biol; 2005 Jan; 15(2):166-70. PubMed ID: 15668174
[TBL] [Abstract][Full Text] [Related]
16. N-terminal and C-terminal cytosine deaminase domain of APOBEC3G inhibit hepatitis B virus replication.
Lei YC; Tian YJ; Ding HH; Wang BJ; Yang Y; Hao YH; Zhao XP; Lu MJ; Gong FL; Yang DL
World J Gastroenterol; 2006 Dec; 12(46):7488-96. PubMed ID: 17167839
[TBL] [Abstract][Full Text] [Related]
17. APOBEC3G is a single-stranded DNA cytidine deaminase and functions independently of HIV reverse transcriptase.
Suspène R; Sommer P; Henry M; Ferris S; Guétard D; Pochet S; Chester A; Navaratnam N; Wain-Hobson S; Vartanian JP
Nucleic Acids Res; 2004; 32(8):2421-9. PubMed ID: 15121899
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the catalytic domain of HIV-1 restriction factor APOBEC3G in complex with ssDNA.
Maiti A; Myint W; Kanai T; Delviks-Frankenberry K; Sierra Rodriguez C; Pathak VK; Schiffer CA; Matsuo H
Nat Commun; 2018 Jun; 9(1):2460. PubMed ID: 29941968
[TBL] [Abstract][Full Text] [Related]
19. Cytidine deaminases APOBEC3G and APOBEC3F interact with human immunodeficiency virus type 1 integrase and inhibit proviral DNA formation.
Luo K; Wang T; Liu B; Tian C; Xiao Z; Kappes J; Yu XF
J Virol; 2007 Jul; 81(13):7238-48. PubMed ID: 17428847
[TBL] [Abstract][Full Text] [Related]
20. [Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].
Fan B; Cen S; Jiang JD
Yao Xue Xue Bao; 2008 Jul; 43(7):678-82. PubMed ID: 18819469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
